Vatelizumab Terminated Phase 2 Trials for Relapsing Remitting Multiple Sclerosis (RRMS) Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Terminated | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT02306811 | Efficacy and Safety of Vatelizumab in Patients Who Completed Treatment in Study DRI13839 | |
| NCT02222948 | Efficacy and Safety of Vatelizumab in Patients With Relapsing-Remitting Multiple Sclerosis |